Tourette Syndrome
A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)
Drugs by status
Approved for this indication (3)
Phase 4 trials (7)
Phase 3 trials (8)
Phase 2 trials (19)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (14)
- Shire
- National Institutes of Health (NIH)
- National Institute of Mental Health (NIMH)
- Albany Medical College
- Emory University
- Hoosier Cancer Research Network
- Johns Hopkins University
- New York University
- Parkinson's Disease and Movement Disorders Center
- University of South Florida
- University of Toronto
- Yale University
- Icahn School of Medicine at Mount Sinai
- Youthdale Treatment Centres
Organization Involved with Phase 3 Indications (15)
- Tasly Pharmaceuticals, Inc.
- Boehringer Ingelheim
- German Research Foundation
- National Center for Research Resources (NCRR)
- Baylor University
- Gottfried Wilhelm Leibniz Universität Hannover
- Nanjing University
- Seoul National University
- Capital Medical University
- Tianjin University of Traditional Chinese Medicine
- Zhejiang University
- Liaoning Hospital of Traditional Chinese Medicine
- Henan Medical University
- Therapix Biosciences Ltd.
- Nuvelution TS Pharma, Inc.
Organization Involved with Phase 2 Indications (21)
- Abide Therapeutics
- Bausch Health Companies
- AstraZeneca
- Pfizer
- FGK Clinical Research GmbH
- Neurocrine Biosciences
- Psyadon Pharma
- Synchroneuron Inc.
- Nanjing Medical University
- University of Rochester
- University of California, San Francisco
- University of Cincinnati
- Bioanalytical Systems, Inc.
- University of Poitiers
- American Academy of Child Adolescent Psychiatry.
- CogState Ltd.
- Tourette Association of America
- China Medical University
- Emalex Biosciences
- Hannover Medical School
- OMNI Medical Services, LLC
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (9)